Saatja: "Tiiu Noobel" <
[email protected]>
Saaja:
[email protected], "Enda Veskimäe" <
[email protected]>, "Maret Voore (SM)" <
[email protected]>
Teema: FW: Summary report 87th meeting of the Standing Committee on Biocidal Products, 19 March 2025 - Ares(2025)2927827
Kuupäev: 2025-04-10 10:31
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Tere!
Edastan.
Parimate soovidega
Tiiu Noobel
Sekretär
Eesti Vabariigi alaline esindus EL juures
Rue Guimard 11/13, 1040 Brüssel
Tel: + 32 2227 4337,
[email protected]
https://eu.mfa.ee/et/
-----Original Message-----
From: Esindus EL juures üldaadress <
[email protected]>
Sent: Thursday, April 10, 2025 11:46 AM
To: Tiiu Noobel <
[email protected]>
Subject: FW: Summary report 87th meeting of the Standing Committee on
Biocidal Products, 19 March 2025 - Ares(2025)2927827
-----Original Message-----
From: DOLHA Elena Adriana (SANTE) <
[email protected]>
Sent: Thursday, April 10, 2025 11:39 AM
To: (Mission of Iceland to the EU = Mission de l'Islande auprès de l'UE)
<
[email protected]>; (Mission of Liechtenstein to the EU = MIssion du
Liechtenstein auprès de l'UE) <
[email protected]>; (Mission
of Switzerland to the EU = Mission de la Suisse auprès de l'UE)
<
[email protected]>; (Permanent Representation of Austria =
Représentation permanente de l'Autriche) <
[email protected]>;
(Permanent Representation of Belgium = Représentation permanente de la
Belgique) <
[email protected]>; (Permanent Representation of
Bulgaria = Représentation permanente de la Bulgarie)
<
[email protected]>; (Permanent Representation of Croatia =
Représentation permanente de la Croatie) <
[email protected]>; (Permanent
Representation of Cyprus = Représentation permanente de Chypre)
<
[email protected]>; (Permanent Representation of Denmark =
Représentation permanente du Danemark) <
[email protected]>; Esindus EL juures
üldaadress <
[email protected]>; (Permanent Representation of Finland =
Représentation permanente de la Finlande) <
[email protected]>;
(Permanent Representation of France = Représentation permanente de la
France) <
[email protected]>; (Permanent
Representation of Germany = Représentation permanente de l'Allemagne)
<
[email protected]>; (Permanent Representation of Greece =
Représentation permanente de la Grèce) <
[email protected]>;
(Permanent Representation of Hungary = Représentation permanente de la
Hongrie) <
[email protected]>; (Permanent Representation of Ireland =
Représentation permanente de l'Irlande) <
[email protected]>; (Permanent
Representation of Italy = Représentation permanente de l'Italie =
Rappresentanza Permanente d’Italia presso l’Uni... <
[email protected]>;
(Permanent Representation of Latvia = Représentation permanente de la
Lettonie) <
[email protected]>; (Permanent Representation of Lithuania =
Représentation permanente de la Lituanie) <
[email protected]>; (Permanent
Representation of Luxembourg = Représentation permanente du Luxembourg)
<
[email protected]>; (Permanent Representation of Malta =
Représentation permanente de Malte) <
[email protected]>; (Permanent
Representation of Netherlands = Représentation permanente des Pays-Bas)
<
[email protected]>; (Permanent Representation of Poland = Représentation
permanente de la Pologne) <
[email protected]>; (Permanent Representation
of Portugal = Représentation permanente du Portugal) <
[email protected]>;
(Permanent Representation of Romania = Représentation permanente de la
Roumanie) <
[email protected]>; (Permanent Representation of Slovakia =
Représentation permanente de la Slovaquie) <
[email protected]>; (Permanent
Representation of Slovenia = Représentation permanente de la Slovénie)
<
[email protected]>; (Permanent Representation of Spain = Représentation
permanente d'Espagne) <
[email protected]>; (Permanent
Representation of Sweden = Représentation permanente de Suède)
<
[email protected]>; (Permanent Representation of the Czech
Republic = Représentation permanente de la République tchèque)
<
[email protected]>
Subject: Summary report 87th meeting of the Standing Committee on Biocidal
Products, 19 March 2025 - Ares(2025)2927827
Dear all,
Please find attached the summary report of the Standing Committee on
Biocidal Products 19 march 2025.
Kind regards,
Elena Dolha
Ref. Ares(2025)2927827 - 10/04/2025
EUROPEAN COMMISSION
Health and Food Safety Directorate General
sante.g.3(2025)4319821
87th Standing Committee on Biocidal Products
19 March 2025
CIRCABC Link: https://circabc.europa.eu/ui/group/8b6b0199-c74b-43bd-a9dd-
79bdcae3b825/library/9e8ba86c-5490-4874-86b4-8d46f1414a09?p=1&n=10&sort=modified_DESC
SUMMARY REPORT
A.01 Adoption of the Agenda
The agenda was adopted.
A.02 Adoption of the minutes of the 86th SCBP meeting
The minutes of the 86th SCBP meeting were adopted.
A.03 Discussion on the application of approval of formaldehyde released from the
reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1), as
an existing active substance for use in biocidal products of product-types 2, 6, 11
and 13 , and of reaction products of paraformaldehyde and 2-
hydroxypropylamine (ratio 3:2) as an existing active substance for use in biocidal
products of product-types 2, 6, 11, 12 and 13
A discussion took place on the application of approval of formaldehyde released from
the reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1), as an
existing active substance for use in biocidal products of product-types 2, 6, 11 and 13,
and of reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2) as
an existing active substance for use in biocidal products of product-types 2, 6, 11, 12
and 13.
A.04 Discussion on the application of approval of DBNPA as an existing active
substance for use in biocidal products of product-type 11
A discussion took place on the application of approval of DBNPA as an existing active
substance for use in biocidal products of product-type 11.
A.05 Discussion on the application of renewal of approval of medetomidine as an
existing active substance for use in biocidal products of product-type 21
A discussion took place on the application of renewal of approval of medetomidine as
an existing active substance for use in biocidal products of product-type 21.
A.06 Information on a draft Commission Implementing Regulation specifying a
procedure for the authorisation of same biocidal products in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council
(repealing Commission Implementing Regulation (EU) No 414/201)
The Commission provided information on a draft Implementing Regulation specifying
a procedure for the authorisation of same biocidal products in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council (repealing
Commission Implementing Regulation (EU) No 414/2013).
A.07 Information on the unresolved objections regarding the conditions for granting an
authorisation for the biocidal product families Cypermethrin liquids and
Cypermethrin solids, and on the biocidal product Icon 10 CS, in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council
The Commission informed that internal discussions are still on-going within the
Commission.
A.08 Information on decisions on amendments to Union authorisations under
preparation or published
The Commission informed on amendments to Union authorisations under preparation
or published. The Commission recalled the importance of the quality check of the
translations of the Summary of Products Characteristics annexed to the authorisation.
B.01 Exchange of views and possible opinion of the Committee on a draft
Commission Implementing Decision on the non-approval of ethylene oxide for use
in biocidal products of product type 2 in accordance with Regulation (EU) No
528/2012 of the European Parliament and of the Council
The Commission introduced the draft Decision. A discussion took place and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.02 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as
an existing active substance for use in biocidal products of product-type 6 in
accordance with Regulation (EU) No 528/2012 of the European Parliament and of
the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.03 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation approving formic acid as an existing active substance
for use in biocidal products of product-type 6 in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.04 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation approving 1,2-Benzisothiazol-3(2H)-one (BIT) as an
existing active substance for use in biocidal products of product-types 6 and 13 in
accordance with Regulation (EU) No 528/2012 of the European Parliament and of
the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.05 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation (EU) granting a Union authorisation for the biocidal
product family ‘B.Braun Medical Propanol Family’ in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.06 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation (EU) granting a Union authorisation for the biocidal
product family ‘BPF Propan-2-ol Dr Deppe’ in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.07 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation (EU) granting a Union authorisation for the single
biocidal product ‘Fernox Biocide AF10’, in accordance with Regulation (EU) No
582/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.08 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation (EU) granting a Union authorisation for the single
biocidal product ‘Hydrocid 306’, in accordance with Regulation (EU) No 582/2012
of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.09 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Regulation (EU) granting a Union authorisation for the biocidal
product family ‘PAA family UCO Group’, in accordance with Regulation (EU) No
582/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place, and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
B.10 Exchange of views and possible opinion of the Committee on a draft Commission
Implementing Decision concerning the extension of the action taken by the
Environment Agency of Luxembourg permitting the making available on the
market and use of the biocidal product Biobor JF in accordance with Regulation
(EU) No 528/2012 of the European Parliament and of the Council
The Commission introduced the draft Decision. A discussion took place and the
Commission informed that the draft will be included in the next written consultation of
the Standing Committee.
Vote Postponed
C.01 Exchange of views of the Committee on a draft Commission Implementing
Regulation amending Implementing Regulation (EU) No 564/2013 as regards the
adaptation of fees to inflation
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.02 Exchange of views of the Committee on a draft Commission Implementing
Regulation approving 2-methyl-2H-isothiazol-3-one (MIT) as an existing active
substance for use in biocidal products of product-type 6 in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.03 Exchange of views of the Committee on a draft Commission Implementing
Regulation approving 2-methyl-2,3-dihydro-1,2-thiazol-3-one hydrochloride for
use in biocidal products of product type 6 in accordance with Regulation (EU) No
528/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.04 Exchange of views of the Committee on a draft Commission Implementing
Regulation approving peracetic acid generated from 1,3-diacetyloxypropan-2-yl
acetate and hydrogen peroxide as an existing active substance for use in biocidal
products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.05 Exchange of views of the Committee on a draft Commission Implementing
Regulation renewing the approval of epsilon-metofluthrin as an active substance
for use in biocidal products of product type 18 in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.06 Exchange of views of the Committee on a draft Commission Implementing
Decision repealing Implementing Decision (EU) 2024/2460 postponing the expiry
date of the approval of metofluthrin for use in biocidal products of product-type
18 in accordance with Regulation (EU) No 528/2012 of the European Parliament
and of the Council
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.07 Exchange of views of the Committee on a draft Commission Implementing
Decision on the non-approval of epsilon-metofluthrin for use in biocidal products
of product type 19 in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council
As the draft Decision was not yet available, no discussion took place on this agenda
item.
C.08 Exchange of views of the Committee on a draft Commission Implementing
Decision not approving certain active substances for use in biocidal products in
accordance with Regulation (EU) No 528/2012 of the European Parliament and of
the Council
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.09 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval of nonanoic acid for use
in biocidal products of product-type 2
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.10 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval of bis(N-cyclohexyl-
diazenium-dioxy)-copper (Cu-HDO) for use in biocidal products of product-type
8
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.11 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval decanoic acid for use in
biocidal products of product-type 4
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.12 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval octanoic acid for use in
biocidal products of product-type 8
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.13 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval iodine for use in biocidal
products of product-type 3
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.14 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval polyvinylpyrrolidone
iodine for use in biocidal products of product-types 1 and 3
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.15 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval 1R-trans phenothrin for
use in biocidal products of product-type 18
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.16 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval S-methoprene for use in
biocidal products of product-type 18
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.17 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval medetomidine for use in
biocidal products of product-type 21
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.18 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval IPBC for use in biocidal
products of product-type 8
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.19 Exchange of views of the Committee on a draft Commission Implementing
Decision (EU) postponing the expiry date of the approval DDACarbonate for use
in biocidal products of product-type 8
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.20 Exchange of views of the Committee on a draft Commission Implementing
Regulation (EU) granting a Union authorisation for the biocidal product family
‘desmanol pure’ in accordance with Regulation (EU) No 528/2012 of the European
Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.21 Exchange of views of the Committee on a draft Commission Implementing
Regulation (EU) granting a Union authorisation for the single biocidal product
‘exeol air cid 01’, in accordance with Regulation (EU) No 582/2012 of the
European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.22 Exchange of views of the Committee on a draft Commission Implementing
Regulation (EU) granting a Union authorisation for the biocidal product family
‘PRODHYNET's Lactic acid based products’, in accordance with Regulation (EU)
No 582/2012 of the European Parliament and of the Council
The Commission introduced the draft Regulation. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.23 Exchange of views of the Committee on a draft Commission Implementing
Regulation granting a Union authorisation for the biocidal product family
‘CHLOROCRESOL BASED PRODUCTS-CID Lines NV’ in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council
The Commission explained that no documents were provided but that following the
receipt of the Agency’s opinion on an Article 75(1)(g) request a revised version will be
prepared for the next meeting.
C.24 Exchange of views of the Committee on a draft Commission Implementing
Decision concerning the extension of the action taken by the Ministry of Health of
the Czech Republic permitting the making available on the market and use of the
biocidal product Tandem in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
C.25 Exchange of views of the Committee on a draft Commission Implementing
Decision concerning the extension of the action taken by the Dutch Ministry of
Infrastructure and Water Management permitting the making available on the
market and use of the biocidal product Biobor JF in accordance with Regulation
(EU) No 528/2012 of the European Parliament and of the Council
The Commission introduced the draft Decision. A discussion took place and the
Committee agreed that the draft will be included in a written consultation of the
Standing Committee as soon as possible.
Electronically signed on 09/04/2025 12:23 (UTC+02) in accordance with Article 11 of Commission Decision (EU) 2021/2121
Ref. Ares(2025)2927827 - 10/04/2025
EUROPEAN COMMISSION
HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL
sante.g.3(2025)4319821
To: Permanent Representations of all 27 Member States
Missions of Iceland, Norway and Switzerland
Copy to: Contacts Standing Committee on Biocidal Products of all 27
Member States - preset
Contacts DG Health and Food Safety and other - preset
Summary Report
Health and Food Safety Directorate General / Unit E4
Meeting: Standing Committee on Biocidal Products
Date: 19 March 2025
Summary Report: Attached in Annex 1
Please find attached the Summary Report of the Standing Committee Meeting on Biocidal
Products, held on 19 March 2025.
N.B. The drafts on which the Committee expressed an opinion are subject to a defined
procedure in relation to the formal adoption by the Commission.
BITTERHOF Almut
Acting Head of Unit
Annex 1 – Summary Report
HANS INGELS(GROW.F.2)
DE AVILA Cristina(ENV.B.2)
Electronically signed on 09/04/2025 12:23 (UTC+02)
European in accordance
Commission, – Belgium
B-1049 Brusselswith Article 11 of Commission Decision (EU) 2021/2121
Telephone (+32-2) 299.11.11 Office B-B232 03/071 Telephone direct line (+32-2) 296.33.56
E-Mail-Address:
[email protected]